- Home
- EOCN vs SNES Comparison
EOCN vs SNES Comparison
Compare EOCN & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EOCN | SNES |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.9M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | EOCN | SNES |
|---|---|---|
| Price | $3.03 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.9K | ★ 2.5M |
| Earning Date | 11-25-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.99 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $600,000.00 |
| Revenue This Year | N/A | $30.39 |
| Revenue Next Year | N/A | $55.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 132.56 |
| 52 Week Low | $2.33 | $0.55 |
| 52 Week High | $3.80 | $3.76 |
Technical Indicators
Market Signals| Indicator | EOCN | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 42.34 | 56.09 |
| Support Level | $2.33 | $0.59 |
| Resistance Level | $3.80 | $0.90 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 53.85 | 70.90 |
Price Performance
Historical ComparisonAbout EOCN Eocene Ltd. Ordinary Shares
Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.